Skip to content

Clinical trials

Completed Phase 3 Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vascular Diseases Phase: Phase 3 Status: Completed Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20085
20096
20101
20111
20122
20141
20151
20161
20171
20181
20192
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)12
Takeda6
Abbott Medical Devices4
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Amarin Pharma Inc.1
Bayer1
Brigham and Women's Hospital1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vascular Diseases47
Cardiovascular Diseases31
Hypertension23
Heart Diseases21
Myocardial Ischemia8
Coronary Artery Disease7
Coronary Disease6
Essential Hypertension5
Coronary Stenosis4
Stroke4

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.